Cameroon has initiated the world's first large-scale malaria vaccine program for children, marking a significant milestone in the fight against the disease in Africa.
The campaign, launched in the Central African nation, aims to combat the high mortality rate from malaria, which accounts for about 95% of global deaths.
The vaccine, known as RTSS and developed by GlaxoSmithKline, is designed to work in conjunction with other preventative measures.
This initiative is a crucial step in addressing the devastating impact of malaria, which claims the lives of over 600,000 people annually, with a majority being young children.
The World Health Organization supports this effort as a vital strategy in reducing the burden of malaria in Africa.